Smartwatch and app aim to track lung cancer symptoms in real time
NCT ID NCT05370469
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a remote monitoring system—including a smartphone app, a Fitbit, and a smart pill cap—can effectively track symptoms and side effects in 30 lung cancer patients taking oral targeted therapy. Participants will use the system for up to 24 weeks, and the goal is to see if it's feasible to capture symptom data in real time. The results will help design better ways to manage treatment side effects and improve quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- remote monitoring system (smartphone app, Fitbit, smart pill cap)
- What this could lead to
- If successful, this could lead to a real-time symptom tracking system that helps doctors better manage side effects and improve quality of life for lung cancer patients.
- What could go wrong
- This is a small, early feasibility study with only 30 participants, so results may not apply to all patients. The system relies on patients consistently using the devices, which may be challenging.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALK GENE MUTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Virginia
Charlottesville, Virginia, 22908, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Could a bronchial wash detect lung cancer mutations faster?